Immunitybio Inc (IBRX)

EBITDA Growth

-279.51%

Quarterly · Period ending:

IBRX logo

IBRX EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-279.51%
IBRX Quarterly EBITDA YoY % (59.67% → -279.51%)
High-resolution chart · PNG

IBRX ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-279.5082%
-517.1913%
22.6421%
12.8866%
34.6845%
0.4414%
79.6101%
26.7777%
10.0073%
-18.5692%
-164.0029%
36.5652%
-28.6266%
6.4781%
10.706%
-8.9784%
3.752%
-18.4503%
-182.9294%
-30.6619%
-76.5269%
-131.8694%
-54.0683%
-364.259%
-207.0009%
-115.7548%
-31.7281%
35.8192%
40.5122%
42.8214%
36.9535%
6.1943%
-15.1125%
-10.9892%
-2.421%
28.687%
34.599%
22.7465%
70.6575%
26.9191%
59.6708%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.